|
Fonseca-Santos M, Bailen R, Lopez-Godino O, Herruzo-Delgado B, Bermudez MA, Garcia-Cadenas I, Huguet-Mas M, Ferra-Coll C, Esquirol A, Cortes-Rodriguez M, Yanez-Sansegundo L, Pascual-Cascon MJ, Heras I, Kwon M, Lopez-Corral L; Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular. Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC. Transplantation. 2024 Oct 1;108(10):2134-2143. doi: 10.1097/TP.0000000000005034. Epub 2024 Sep 24. PubMed PMID: 38685204.
AÑO: 2024; IF: 5.3
|
38685204
|
Pinana JL, Vazquez L, Heras I, Aiello TF, Lopez-Corral L, Arroyo I, Soler-Espejo E, Garcia-Cadenas I, Garcia-Gutierrez V, Aroca C, Chorao P, Olave MT, Lopez-Jimenez J, Gomez MA, Arellano E, Cuesta-Casas M, Avendano-Pita A, Gonzalez-Santillana C, Hernandez-Rivas JA, Roldan-Perez A, Mico-Cerda M, Guerreiro M, Morell J, Rodriguez-Galvez P, Labrador J, Campos D, Cedillo A, Vidal CG, Martino R, Solano C. Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy. Front Oncol. 2024 Jun 19;14:1389345. doi: 10.3389/fonc.2024.1389345. eCollection 2024. PubMed PMID: 39015498; PubMed Central PMCID: PMC11250586.
AÑO: 2024; IF: 3.5
|
|
Kwon M, Gomez-Centurion I, Oarbeascoa G, Torres M, Martinez AP, Suarez-Lledo M, Chinea A, Cascon MJP, Vazquez L, Espigado I, Izquierdo I, Parody R, Cadenas IG, Calbacho M, Sierra PG, Heras I, Yanez L, Torrent A, Bautista G, Gonzalez S, Roldan E, Vallejo JC, Bailen R, Borrero A, Lopez-Jimenez J, Casas MAC, Solano C; Spanish Group of Hematopoietic Stem Cell Transplantation and Cell Therapy (GETH-TC). Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in Spain. Transplant Cell Ther. 2024 Oct;30(10):1033.e1-1033.e8. doi: 10.1016/j.jtct.2024.06.009. Epub 2024 Jun 12. PubMed PMID: 38871055.
AÑO: 2024; IF: 3.6
|
|
Robin M, Gras L, Koster L, Saccardi R, Finke J, Forcade E, Rovira M, Kobbe G, Remenyi P, Apperley J, Smaranda A, Bay JO, Casper J, de Wreede LC, Giebel S, Grillo G, Heras I, Potter V, Tischer J, Trociukas I, Nachbaur D, Drozd-Sokolowska J, Raj K, Gurnari C, Yakoub-Agha I, Onida F, Scheid C, McLornan D. Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature. Bone Marrow Transplant. 2023 Aug;58(8):942-945. doi: 10.1038/s41409-023-01991-9. Epub 2023 Apr 25. No abstract available. PubMed PMID: 37185613.
AÑO: 2023; IF: 4.5
|
|
Cruz D, Rodriguez-Romanos R, Gonzalez-Bartulos M, Garcia-Cadenas I, de la Camara R, Heras I, Buno I, Santos N, Lloveras N, Velarde P, Tuset E, Martinez C, Gonzalez M, Sanz GF, Ferra C, Sampol A, Coll R, Perez-Simon JA, Lopez-Jimenez J, Jurado M, Gallardo D. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors. Front Immunol. 2023 Jan 20;14:1066393. doi: 10.3389/fimmu.2023.1066393. eCollection 2023. PubMed PMID: 36742309; PubMed Central PMCID: PMC9897054.
AÑO: 2023; IF: 5.7
|